The nation of Zimbabwe has turned down a substantial American healthcare agreement worth 367 million US dollars (£272m) over five years due to Washington's demand for sensitive data.
This rejection became public following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
A government representative has since explained that the US was demanding access to biological samples for research and commercial purposes but refused to guarantee the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued talks to secure a deal agreeable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Background
This development comes after a comparable case in neighbouring Kenya, where a court halted a related health funding agreement after legal challenges were raised about the security of citizens' health data.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and accountability.
As per statements, Sixteen nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," his statement read.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the end products would be available to our people if a new pandemic arise."
Sovereignty and Global Health
He also said that the American exit from the global health body and its push of one-on-one health agreements were upending systems previously set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage potential pandemics.
"This mechanism is designed to ensure that when a nation provides its information, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be designed in a way that honours the independence and dignity of each country."
Medical Community Response
Medical experts expressed it recognised the government's concerns, but urged that negotiations must proceed considering much of the country's Aids initiatives depended on external financing.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it said.
The situation highlights the complex tensions between accepting crucial foreign assistance and protecting local interests in an ever more interconnected world.